These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8626240)

  • 1. Quinoxapeptins: novel chromodepsipeptide inhibitors of HIV-1 and HIV-2 reverse transcriptase. I. The producing organism and biological activity.
    Lingham RB; Hsu AH; O'Brien JA; Sigmund JM; Sanchez M; Gagliardi MM; Heimbuch BK; Genilloud O; Martin I; Diez MT; Hirsch CF; Zink DL; Liesch JM; Koch GE; Gartner SE; Garrity GM; Tsou NN; Salituro GM
    J Antibiot (Tokyo); 1996 Mar; 49(3):253-9. PubMed ID: 8626240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of inhibition of retroviral reverse transcriptase.
    Balzarini J; De Clercq E
    Methods Enzymol; 1996; 275():472-502. PubMed ID: 9026655
    [No Abstract]   [Full Text] [Related]  

  • 3. A new series of pyridinone derivatives as potent non-nucleoside human immunodeficiency virus type 1 specific reverse transcriptase inhibitors.
    Dollé V; Fan E; Nguyen CH; Aubertin AM; Kirn A; Andreola ML; Jamieson G; Tarrago-Litvak L; Bisagni E
    J Med Chem; 1995 Nov; 38(23):4679-86. PubMed ID: 7473595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.
    Das K; Sarafianos SG; Clark AD; Boyer PL; Hughes SH; Arnold E
    J Mol Biol; 2007 Jan; 365(1):77-89. PubMed ID: 17056061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interface peptides as structure-based human immunodeficiency virus reverse transcriptase inhibitors.
    Divita G; Baillon JG; Rittinger K; Chermann JC; Goody RS
    J Biol Chem; 1995 Dec; 270(48):28642-6. PubMed ID: 7499382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple weak intercalation as a strategy for the inhibition of polymerases.
    Jain N; Friedman SH
    Bioorg Med Chem Lett; 2019 Feb; 29(3):424-429. PubMed ID: 30579791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
    Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
    J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct.
    Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ
    Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of chimeric human immunodeficiency virus types 1 and 2 reverse transcriptases for structure-function analysis and for mapping susceptibility to nonnucleoside inhibitors.
    Yang G; Song Q; Charles M; Drosopoulos WC; Arnold E; Prasad VR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):326-33. PubMed ID: 8601218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of interactions of DNA polymerase beta and reverse transcriptases of human immunodeficiency and mouse leukemia viruses with dNTP analogs containing a modified sugar residue.
    Lebedeva NA; Seredina TA; Silnikov VN; Abramova TV; Levina AS; Khodyreva SN; Rechkunova NI; Lavrik OI
    Biochemistry (Mosc); 2005 Jan; 70(1):1-7. PubMed ID: 15701045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxal-5'-phosphate inhibits the polymerase activity of a recombinant RNAase H-deficient mutant of HIV-1 reverse transcriptase.
    Moen LK; Bathurst IC; Barr PJ
    AIDS Res Hum Retroviruses; 1992 May; 8(5):597-604. PubMed ID: 1381204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates.
    Cesarini S; Spallarossa A; Ranise A; Fossa P; La Colla P; Sanna G; Collu G; Loddo R
    Bioorg Med Chem; 2008 Apr; 16(7):4160-72. PubMed ID: 18226532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of inhibition of HIV-1 reverse transcriptase by polyacetylenetriol, a novel inhibitor of RNA- and DNA-directed DNA polymerases.
    Loya S; Rudi A; Kashman Y; Hizi A
    Biochem J; 2002 Mar; 362(Pt 3):685-92. PubMed ID: 11879196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
    Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
    J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases.
    Chen H; Brown D; Gold L
    Methods Enzymol; 1996; 275():503-20. PubMed ID: 9026656
    [No Abstract]   [Full Text] [Related]  

  • 17. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.
    Hsiou Y; Ding J; Das K; Clark AD; Boyer PL; Lewi P; Janssen PA; Kleim JP; Rösner M; Hughes SH; Arnold E
    J Mol Biol; 2001 Jun; 309(2):437-45. PubMed ID: 11371163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
    Shaharabany M; Rice NR; Hizi A
    Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer.
    Perach M; Rubinek T; Hughes SH; Hizi A
    J Mol Biol; 1997 May; 268(3):648-54. PubMed ID: 9171288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New type of HIV drug.
    Treat Rev; 1995 Nov; (no 20):4. PubMed ID: 11363022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.